GGrantIndex
Sort

21,453 grants matching tuberculosis

Molecular Epidemiology and Key Issues of Foodborne Pathogens in Eastern Africa

$148,036
Wondwossen A. Gebreyes · Ohio State University · D43 · FY2011 · TW

Emory/Georgia TB Research Advancement Center (TRAC)

$148,021
Nippie Sarita Shah · Emory University · P30 · FY2024 · AI

IGRA investigation in recently exposed contacts

$148,016
Rodrigo Ribeiro-Rodrigues · Federal University Of Espirito Santo · R01 · FY2016 · AI

SYNTHETIC MODELS FOR MOLYBDOENZYMES ACTIVE SITES AND FUNCTIONS

$148,000
Feifei Li · New Mexico State University Las Cruces · SC2 · FY2018 · GM

Practical Diagnostics for AIDS-Related Pediatric TB,Peru

$147,976
Richard A Oberhelman · Tulane University Of Louisiana · R01 · FY2006 · AI

IGRA investigation in recently exposed contacts

$147,800
Rodrigo Ribeiro-Rodrigues · Federal University Of Espirito Santo · R01 · FY2018 · AI

Translational modeling of individual- and population-level outcomes of novel tuberculosis drug regimens

$147,787
Emily A Kendall · Johns Hopkins University · K08 · FY2021 · AI

MEDICATION MONITOR DEVELOPMENT STRESSING TB AND AIDS

$147,757
Nbs Medical, Inc. · R44 · FY2000 · AI

HIV Basic Science and Cure Research Training for Scientists at the University of Ghana (H-Cure-RT)

$147,680
George Kyei · Washington University · D43 · FY2024 · TW

GAMMA INTERFERON REGULATION OF VITAMIN D ACTION

$147,654
Washington University · R01 · FY2001 · AR

Molecular Epidemiology and Key Issues of Foodborne Pathogens in Eastern Africa

$147,640
Wondwossen A. Gebreyes · Ohio State University · D43 · FY2012 · TW

Combined Phone based video DOT and mobile payments for TB treatment in Cambodia

$147,640
Joanne Yoong · University Of Southern California · R21 · FY2019 · TW

CORE--Biosafety Core

$147,590
Zahra Toossi · Case Western Reserve University · P30 · FY2006 · AI

Molecular Pathogenesis of Infectious Diseases

$147,556
Linda F Van Dyk · University Of Colorado Denver · T32 · FY2021 · AI

Translational modeling of individual- and population-level outcomes of novel tuberculosis drug regimens

$147,550
Emily A Kendall · Johns Hopkins University · K08 · FY2020 · AI

Evidence of the burden of diabetes, gaps in the diabetes cascade-of-care and the impact of care and treatment on diabetes outcomes in HIV-positive and HIV-negative patients in South Africa

$147,528
Alana Teresa Brennan · Boston University Medical Campus · K01 · FY2022 · DK

Evidence of the burden of diabetes, gaps in the diabetes cascade-of-care and the impact of care and treatment on diabetes outcomes in HIV-positive and HIV-negative patients in South Africa

$147,528
Alana Teresa Brennan · Boston University Medical Campus · K01 · FY2023 · DK

Evidence of the burden of diabetes, gaps in the diabetes cascade-of-care and the impact of care and treatment on diabetes outcomes in HIV-positive and HIV-negative patients in South Africa

$147,528
Alana Teresa Brennan · Boston University Medical Campus · K01 · FY2021 · DK

Innate Immunogenetics & Human Infections

$147,523
Thomas R Hawn · University Of Washington · K24 · FY2010 · AI

Husbandry and Management Core

$147,500
Kamm Prongay · Oregon Health & Science University · U42 · FY2022 · OD

Treatment of Latent TB and MDR-TB with FAS20013

$147,456
Albert H. Owens · Fasgen, Inc. · R43 · FY2006 · AI

HIV activation in secondary pulmonary infection

$147,450
Michael D. Weiden · New York University School Of Medicine · K24 · FY2012 · AI

HIV activation in secondary pulmonary infection

$147,450
Michael D. Weiden · New York University School Of Medicine · K24 · FY2011 · AI

Central Africa IeDEA

$147,395
Kathryn M Anastos · Albert Einstein College Of Medicine · U01 · FY2015 · AI

Point-of-care detection of TB and NTM pathogens with Fluorescent Deoxyribozyme Sensors and 3D-printed, battery powered device.

$147,383
Kyle H Rohde · University Of Central Florida · R01 · FY2023 · AI